✦ LIBER ✦

The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia

✍ Scribed by Joseph A. Fontana; John S. Rogers II; John P. Durham

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 956 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860115)57:2<209::aid-cncr2820570204>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrent “Retinoic acid syndrome” durin

Recurrent “Retinoic acid syndrome” during induction of remission in acute promyelocytic leukemia

✍ Avichai Shimoni; Yaakov Maor-Kendler; Miron Prokocimer 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Significant reduction of medical costs b

Significant reduction of medical costs by differentiation therapy with all-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia

✍ Akihiro Takeshita; Hisashi Sakamaki; Shuichi Miyawaki; Toru Kobayashi; Kazutaka 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

Background. Differentiation therapy with all-trans retinoic acid (RA) induces more than 80% complete remission with the least complications in patients with acute promyelocytic leukemia (APL). The authors studied the cost-benefit of this new treatment modality compared with conventional chemotherapy

ALL-TRANS RETINOIC ACID (ATRA) IN THE TR

ALL-TRANS RETINOIC ACID (ATRA) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)

✍ C. S. CHIM; Y. L. KWONG; R. LIANG; Y. C. CHU; C. H. CHAN; L. C. CHAN; K. F. WONG 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

Acute promyelocytic leukemia is characterized by the reciprocal translocation of chromosomes 15 and 17. All-trans retinoic acid (ATRA) efficiently induces differentiation of the abnormal promyelocytes. In this study, we had used ATRA as the primary induction therapy for 17 newly diagnosed patients,

Four years' experience with the treatmen

Four years' experience with the treatment of all-trans retinoic acid in acute promyelocytic leukemia

✍ Dr. Xingzhong Wu; Xuewen Wang; Xiaoping Qien; Hainin Liu; Jianshang Ying; Zhiche 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Treatment of acute promyelocytic leukemi

Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy

✍ Reiko Watanabe; Shinichiro Okamoto; Takanori Moriki; Masahiro Kizaki; Yoko Kawai 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

## Response to "Treatment of Childhood Chronic ITP" Prompted by recent correspondence in the Journal (July 1994), may I contribute the experience from this center in the use of megadose prednisone for chronic immune thrombocytopenic purpura (ITP) in children? A cohort of 4 children received this

13-cis-retinoic acid in the treatment of

13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the eastern cooperative oncology group

✍ Zachary B. Kramer; Laszlo Boros; Peter H. Wiernik; Janet Andersen; John M. Benne 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

The management of acute myeloid leukemia in the elderly (65 years and older) is unsatisfactory because of poor patient tolerance of standard myeloablative chemotherapy. The authors conducted a Phase II study to evaluate the effectiveness and toxicity of 13-cis-retinoic acid (CRA) in the therapy of e